WuXi Biologics (Cayman) Inc
HKEX:2269
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
Reach PLC
LSE:RCH
|
UK |
|
Clemondo Group AB (publ)
F:N170
|
SE |
|
TS Financial Holding Co Ltd
TWSE:2887
|
TW |
|
Ackermans & Van Haaren NV
XBRU:ACKB
|
BE |
|
K
|
Kyogoku Unyu Shoji Co Ltd
TSE:9073
|
JP |
|
West High Yield (WHY) Resources Ltd
XTSX:WHY
|
CA |
|
Sinfonia Technology Co Ltd
TSE:6507
|
JP |
|
C
|
China Minsheng Banking Corp Ltd
XMUN:GHFH
|
CN |
|
HMS Networks AB
STO:HMS
|
SE |
|
A
|
A-1 Acid Ltd
BSE:542012
|
IN |
|
K
|
Kubota Corp
OTC:KUBTF
|
JP |
|
P
|
Petrovietnam Chemical and Services Corp
VN:PVC
|
VN |
|
Independent Bank Corp
NASDAQ:IBCP
|
US |
|
Jesco Holdings Inc
TSE:1434
|
JP |
|
Inter Cars SA
F:7FZ
|
PL |
|
M
|
Microsoft Corp
SGO:MSFT
|
US |
Shareholder Yield
Current shareholder yield for WuXi Biologics (Cayman) Inc is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
WuXi Biologics (Cayman) Inc
| Average Annual Return | 4.48% |
| Standard Deviation of Annual Returns | 64.14% |
| Max Drawdown | -92% |
| Market Capitalization | 221.7B HKD |
| Shares Outstanding | 4 143 560 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
WuXi Biologics (Cayman) Inc's latest stock split occurred on Nov 16, 2020
The company executed a 959692-for-319897 stock split, meaning that for every 319897 shares held, investors received 959692 new shares.
Before the split, WuXi Biologics (Cayman) Inc traded at 244.6 per share. Afterward, the share price was about 84.
The adjusted shares began trading on Nov 16, 2020. This was the only stock split in WuXi Biologics (Cayman) Inc's history.